A brain stroke occurs when blood flow to the brain is disrupted, leading to severe damage. Recognizing symptoms early and ...

All potential acute ischemic stroke patients meeting criteria for the use of IV tPA should be offered treatment. The facts are clear, and all that remains is further provider and patient education.

In Alaska, where access to specialist care is challenging and emergency transfers can be harrowing, providers are using AI to ...

The FDA approved tenecteplase (TNKase) for adult stroke patients, Genentech announced on Monday. A clot-dissolving tissue ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

OBJECTIVE: To determine why patients with ischemic stroke did not receive IV TPA and assess the availability of this therapy to patients with ischemic stroke. METHODS: Consecutive patients with ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...

Medically reviewed by Danielle Weiss, MD Diabetes (also called diabetes mellitus) is a group of conditions that cause the body to be less efficient in managing levels of blood glucose (sugar). People ...

Ischaemic stroke can lead to permanent neurological damage and often death if not diagnosed and treated promptly. There is therefore an urgent need for novel treatment approaches. Now, writing in ...

The stroke-ready designation means that a hospital is equipped to evaluate, stabilize and provide emergency care to patients ...